MedTrace Logo

Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes

NCT04031222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2022-09-13

No results posted yet for this study

Summary

This study intends to assess the role of inflammation in insulin resistant conditions (i.e., obesity and pre-diabetes) and the subsequent development of disease, such as type 2 diabetes (T2D) and cardiovascular disease (CVD), in the adolescent population.

Conditions

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER

  • University of Guelph

    collaborator OTHER

  • Sunnybrook Health Sciences Centre

    collaborator OTHER

  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • Jill K Hamilton, MD · The Hospital for Sick Children

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-19
Primary Completion
2019-02-15
Completion
2019-03-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031222 on ClinicalTrials.gov